S&P 500   3,168.80 (+0.01%)
DOW   28,135.38 (+0.01%)
QQQ   207.19 (+0.33%)
AAPL   275.15 (+1.36%)
FB   194.11 (-1.34%)
MSFT   154.53 (+0.84%)
GOOGL   1,346.87 (-0.12%)
AMZN   1,760.94 (+0.03%)
CGC   20.68 (-2.13%)
NVDA   223.99 (-0.04%)
MU   51.20 (+0.45%)
BABA   204.91 (+0.20%)
GE   11.34 (-0.87%)
TSLA   358.39 (-0.36%)
T   38.26 (-0.23%)
AMD   41.15 (-3.38%)
ACB   2.63 (+1.15%)
F   9.23 (-0.97%)
PRI   136.56 (+0.04%)
NFLX   298.50 (+0.02%)
BAC   34.44 (-0.69%)
GILD   65.77 (-2.75%)
DIS   146.38 (-0.93%)
S&P 500   3,168.80 (+0.01%)
DOW   28,135.38 (+0.01%)
QQQ   207.19 (+0.33%)
AAPL   275.15 (+1.36%)
FB   194.11 (-1.34%)
MSFT   154.53 (+0.84%)
GOOGL   1,346.87 (-0.12%)
AMZN   1,760.94 (+0.03%)
CGC   20.68 (-2.13%)
NVDA   223.99 (-0.04%)
MU   51.20 (+0.45%)
BABA   204.91 (+0.20%)
GE   11.34 (-0.87%)
TSLA   358.39 (-0.36%)
T   38.26 (-0.23%)
AMD   41.15 (-3.38%)
ACB   2.63 (+1.15%)
F   9.23 (-0.97%)
PRI   136.56 (+0.04%)
NFLX   298.50 (+0.02%)
BAC   34.44 (-0.69%)
GILD   65.77 (-2.75%)
DIS   146.38 (-0.93%)
S&P 500   3,168.80 (+0.01%)
DOW   28,135.38 (+0.01%)
QQQ   207.19 (+0.33%)
AAPL   275.15 (+1.36%)
FB   194.11 (-1.34%)
MSFT   154.53 (+0.84%)
GOOGL   1,346.87 (-0.12%)
AMZN   1,760.94 (+0.03%)
CGC   20.68 (-2.13%)
NVDA   223.99 (-0.04%)
MU   51.20 (+0.45%)
BABA   204.91 (+0.20%)
GE   11.34 (-0.87%)
TSLA   358.39 (-0.36%)
T   38.26 (-0.23%)
AMD   41.15 (-3.38%)
ACB   2.63 (+1.15%)
F   9.23 (-0.97%)
PRI   136.56 (+0.04%)
NFLX   298.50 (+0.02%)
BAC   34.44 (-0.69%)
GILD   65.77 (-2.75%)
DIS   146.38 (-0.93%)
S&P 500   3,168.80 (+0.01%)
DOW   28,135.38 (+0.01%)
QQQ   207.19 (+0.33%)
AAPL   275.15 (+1.36%)
FB   194.11 (-1.34%)
MSFT   154.53 (+0.84%)
GOOGL   1,346.87 (-0.12%)
AMZN   1,760.94 (+0.03%)
CGC   20.68 (-2.13%)
NVDA   223.99 (-0.04%)
MU   51.20 (+0.45%)
BABA   204.91 (+0.20%)
GE   11.34 (-0.87%)
TSLA   358.39 (-0.36%)
T   38.26 (-0.23%)
AMD   41.15 (-3.38%)
ACB   2.63 (+1.15%)
F   9.23 (-0.97%)
PRI   136.56 (+0.04%)
NFLX   298.50 (+0.02%)
BAC   34.44 (-0.69%)
GILD   65.77 (-2.75%)
DIS   146.38 (-0.93%)
Log in

NYSE:DVA - Davita Stock Price, Forecast & News

$72.71
-0.53 (-0.72 %)
(As of 12/13/2019 04:00 PM ET)
Today's Range
$72.51
Now: $72.71
$73.91
50-Day Range
$57.83
MA: $68.41
$73.17
52-Week Range
$43.40
Now: $72.71
$73.91
Volume1.21 million shs
Average Volume2.06 million shs
Market Capitalization$9.32 billion
P/E Ratio20.37
Dividend YieldN/A
Beta1.67
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. Read More…

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services
SectorMedical
CUSIP23918K10
Phone720-631-2100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.40 billion
Cash Flow$7.28 per share
Book Value$23.55 per share

Profitability

Net Income$159.39 million

Miscellaneous

Employees77,700
Market Cap$9.32 billion
Next Earnings Date2/12/2020 (Estimated)
OptionableOptionable

Receive DVA News and Ratings via Email

Sign-up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter.


Davita (NYSE:DVA) Frequently Asked Questions

What is Davita's stock symbol?

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

How were Davita's earnings last quarter?

Davita Inc (NYSE:DVA) posted its earnings results on Tuesday, November, 5th. The company reported $1.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $0.29. The business earned $2.90 billion during the quarter, compared to analyst estimates of $2.85 billion. Davita had a return on equity of 19.95% and a net margin of 3.68%. The company's revenue for the quarter was up 2.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.56 earnings per share. View Davita's Earnings History.

When is Davita's next earnings date?

Davita is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Davita.

What guidance has Davita issued on next quarter's earnings?

Davita issued an update on its FY20 earnings guidance on Tuesday, November, 5th. The company provided earnings per share guidance of $5.25-5.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.32.

What price target have analysts set for DVA?

10 brokerages have issued 12 month target prices for Davita's shares. Their forecasts range from $57.00 to $72.00. On average, they anticipate Davita's stock price to reach $65.00 in the next twelve months. This suggests that the stock has a possible downside of 10.6%. View Analyst Price Targets for Davita.

What is the consensus analysts' recommendation for Davita?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Davita.

Has Davita been receiving favorable news coverage?

News stories about DVA stock have trended positive this week, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Davita earned a media sentiment score of 2.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Davita.

Are investors shorting Davita?

Davita saw a decline in short interest in the month of November. As of November 15th, there was short interest totalling 9,030,000 shares, a decline of 8.5% from the October 31st total of 9,870,000 shares. Based on an average daily trading volume, of 2,600,000 shares, the short-interest ratio is presently 3.5 days. Approximately 7.0% of the shares of the stock are sold short. View Davita's Current Options Chain.

Who are some of Davita's key competitors?

What other stocks do shareholders of Davita own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), AutoZone (AZO), Micron Technology (MU), Designer Brands (DBI), United Rentals (URI) and Precision Drilling (PD).

Who are Davita's key executives?

Davita's management team includes the folowing people:
  • Mr. Kent J. Thiry, Chairman & CEO (Age 63)
  • Mr. Joel Ackerman, Chief Financial Officer (Age 54)
  • Mr. James K. Hilger, Chief Accounting Officer (Age 57)
  • Ms. Kathleen Alyce Waters, Chief Legal Officer (Age 51)
  • Mr. Javier J. Rodriguez, Chief Exec. Officer of DaVita Kidney Care (Age 48)

Who are Davita's major shareholders?

Davita's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include State Street Corp (4.09%), Boston Partners (0.64%), Wedge Capital Management L L P NC (0.39%), Poplar Forest Capital LLC (0.31%), Sumitomo Mitsui Trust Holdings Inc. (0.29%) and Parametric Portfolio Associates LLC (0.32%). Company insiders that own Davita stock include Charles Berg, James K Hilger, Pamela M Arway and William L Roper. View Institutional Ownership Trends for Davita.

Which institutional investors are selling Davita stock?

DVA stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Boston Partners, Millennium Management LLC, Nomura Holdings Inc., Worldquant Millennium Advisors LLC, Alberta Investment Management Corp, Speece Thorson Capital Group Inc. and Poplar Forest Capital LLC. View Insider Buying and Selling for Davita.

Which institutional investors are buying Davita stock?

DVA stock was purchased by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, GVO Asset Management Ltd, Squarepoint Ops LLC, State of New Jersey Common Pension Fund D, Maverick Capital Ltd., Robeco Institutional Asset Management B.V., Chicago Equity Partners LLC and FNY Investment Advisers LLC. View Insider Buying and Selling for Davita.

How do I buy shares of Davita?

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Davita's stock price today?

One share of DVA stock can currently be purchased for approximately $72.71.

How big of a company is Davita?

Davita has a market capitalization of $9.32 billion and generates $11.40 billion in revenue each year. The company earns $159.39 million in net income (profit) each year or $3.57 on an earnings per share basis. Davita employs 77,700 workers across the globe.View Additional Information About Davita.

What is Davita's official website?

The official website for Davita is http://www.davita.com/.

How can I contact Davita?

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]


MarketBeat Community Rating for Davita (NYSE DVA)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  430 (Vote Outperform)
Underperform Votes:  481 (Vote Underperform)
Total Votes:  911
MarketBeat's community ratings are surveys of what our community members think about Davita and other stocks. Vote "Outperform" if you believe DVA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DVA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel